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ABSTRACT  
Aims: Self-efficacy beliefs and outcome expectancies are central to Social Cognitive Theory 
(SCT). Alcohol studies demonstrate the theoretical and clinical utility of applying both SCT 
constructs. This study examined the relationship between self-efficacy and outcome 
expectancies in a cannabis treatment sample, and tests formal meditational models. Design: 
Patients referred for cannabis treatment completed a comprehensive clinical assessment, 
including recently validated cannabis expectancy and refusal self-efficacy scales. Setting: A 
hospital alcohol and drug outpatient clinic. Participants: Patients referred for a cannabis 
treatment (N = 1115, mean age 26.29, SD 9.39). Measurement: The Cannabis Expectancy 
Questionnaire (CEQ), Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) were 
completed, along with measures of cannabis severity (Severity of Dependence Scale [SDS]) 
and cannabis consumption. Findings: Both cannabis expectancy and cannabis refusal self-
efficacy were significant predictors of cannabis problems. When mediation was examined, 
partial support was observed for self-efficacy mediating expectancy beliefs. Conclusions: 
Both constructs appear important to cannabis use disorders and may have utility in cannabis 
prevention and treatment.  
 
 
 
 
Key Words:  Cannabis; Expectancy; Self-Efficacy; Mediation; Dependence; Social Cognitive 
Theory  
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INTRODUCTION 
Worldwide, cannabis remains the most widely used illicit substance. Population 
estimates report between 2.8 – 4·5% of the adult global population are current cannabis users, 
with estimated prevalence rates around 10% in many high-income countries [1]. Applying 
Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria, the 12 month 
prevalence rates of cannabis use disorders in the United States is 1.5% [2]. The associated 
impact on morbidity- particularly mental health problems, is well documented [3]. 
Approximately half of the estimated risk of problematic cannabis use is genetic in origin 
[4,5], leaving substantial contributions from other factors.  
The contribution of environmental and cognitive mechanisms to cannabis misuse is 
not well understood. Social Cognitive Theory (SCT) [6,7] remains one of the most widely 
supported cognitive theories of the acquisition and maintenance of human behaviour. In SCT, 
Bandura identifies two constructs: self-efficacy and outcome expectancies. Outcome 
expectancies, sometimes referred to as “if... then” statements, are the perceived behavioural 
and affective consequences of engaging in specific behaviours. Self-efficacy refers to a 
person’s belief they can successfully or unsuccessfully regulate their behaviour. Bandura [8] 
promotes self-efficacy beliefs as the “foundation of human agency” (p. 3). Both belief 
systems have been applied in substance use disorder prevention and treatment research, albeit 
with a strong focus on alcohol [9,10,11]. More recently, cognitive mechanisms of cannabis 
expectancy and cannabis self-efficacy have been examined.  
A number of cannabis expectancy measures have been developed and validated in 
non-clinical samples (Marijuana Effect Expectancy Questionnaire [12], Marijuana 
Expectancy Inventory for Children and Adolescents [13], Memory Model-Based Marijuana 
Expectancy Questionnaire [14], Adolescent Cannabis Expectancies Questionnaire [15]). The 
Marijuana Effect Expectancy Questionnaire has also been validated though confirmatory 
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factor analysis in a polysubstance treatment setting [16]. Factor structures typically highlight 
positive (e.g. “I have more self-confidence when smoking cannabis”) and negative (e.g. 
“Smoking cannabis makes me confused”) features of cannabis expectancies. Studies 
consistently show that positive cannabis expectancies are associated with cannabis use and 
consumption, whereas negative cannabis expectancies are associated with non-use or reduced 
consumption.  
The Cannabis Expectancy Questionnaire (CEQ) [17] is the first instrument to date to 
be validated in cannabis users in treatment [18]. The two factors observed in the previous 
non-clinical studies - negative expectancy and positive expectancy - were also evident in this 
clinical sample. Positive cannabis expectancies were associated with higher weekly cannabis 
use, and negative expectancy with higher dependence severity. Positive and negative 
expectancies also interacted to predict functioning on the General Health Questionnaire 
(GHQ-28) scales of somatic symptoms, anxiety, social dysfunction and depression.  
Cannabis self-efficacy represents the second component of SCT. As with cannabis 
expectancies, they are associated with consumption and treatment outcomes [19]. Stephens et 
al. [20] reported that Self-Efficacy for Avoiding Marijuana Use scores [21] at the end of 
treatment added novel variance above consumption, temptation, coping, stress and peer use, 
to predict cannabis consumption up to 12 months post treatment. In a psychologically-based, 
multi-arm cannabis treatment study, patients’ self-efficacy [20,21] was reported by Litt et al. 
[22] as the primary mechanism predicting abstinence 12 months post treatment, regardless of 
the psychological treatment approach employed. Litt et al. [23] additionally identified that 
self-efficacy changes over the course of treatment were related to coping skill development, 
and that both skill acquisition and self-efficacy contributed to reduced cannabis use. The 
authors concluded that treatment effects are directly related to the capacity of the intervention 
to reliably increase patient self-efficacy. Adapting the Smoking Situational Confidence 
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Questionnaire, Burleson and Kaminer [24] reported that higher situational self-efficacy 
beliefs predicted cannabis abstinence during treatment. Similar to Litt et al. [21], self-efficacy 
improved prediction of abstinence independent of treatment approach.  
Despite these promising findings, measurement of cannabis self-efficacy did not 
minimum psychometric requirements. The Cannabis Refusal Self-Efficacy Questionnaire 
(CRSEQ) [25] has recently validated in a cannabis treatment population [26]. It employed 
both exploratory and confirmatory construct validity, concurrent validity and gender 
invariance and reliability testing. This multi-dimensional instrument measures three 
components of cannabis self-efficacy: Emotional Relief, Opportunistic and Social 
Facilitation. The sub-scales uniquely predict cannabis use and cannabis dependence severity 
and are similar in structure to the self-efficacy beliefs identified in alcohol refusal [27].  
Up to now, cannabis expectancy and cannabis refusal self-efficacy have only been 
examined independently. This approach does not take full advantage of SCT. While findings 
from alcohol studies repeatedly demonstrate the predictive power of self-efficacy [e.g. 28, 29, 
30], including both SCT constructs gives additional theoretical and clinical utility [9,31]. 
Cross-sectional studies show drinking refusal self-efficacy adds unique variance over alcohol 
expectancies in predicting alcohol consumption and problem drinking [32,33, 34,35]. 
Longitudinally, both alcohol expectancy and drinking refusal self-efficacy predict alcohol 
consumption over a [36] and binge drinking 3 months later [37]. Young et al. [38] found that 
both alcohol expectancy and self-efficacy could discriminate between patients who 
successfully completed alcohol dependence treatment from those who did not. Where formal 
mediation has been tested, both cross-sectional [39] and prospective [40] evidence suggests a 
significant proportion of the risk conveyed by alcohol expectancies for problem drinking, is 
mediated by self-efficacy.  
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Treatment studies have identified self-efficacy (as measured by the Drinking Refusal 
Self-Efficacy Questionnaire, DRSEQ [27, 41]) as the only significant mediator of treatment 
outcomes when readiness to change, perceived risk, norm estimates and positive drinking 
expectancies were also considered [42]. However, Kadden and Litt’s [19] review on 
substance abuse self-efficacy concludes that the increased recent interest in the role of self-
efficacy as a mediator of substance abuse problems would benefit from further empirical 
support. A mediating role for self-efficacy makes theoretical and clinical sense. Almost two 
decades ago, Oei and Baldwin [43] noted that when an individual is presented with a 
decision, the outcome will also be dependent upon the strength of the individual’s belief that 
they are able to resist or refuse alcohol.  
SCT has had considerable impact on our understanding of human behaviour, and 
along with other cognitive models, has profoundly influenced our understanding of the use 
and maintenance of substance use disorders [44,45]. Evidence suggests that consideration of 
concurrent expectancy and self-efficacy beliefs provides more powerful prediction of use and 
treatment outcome. More recent research points to a meditational process. Psychometrically 
robust cannabis expectancy and cannabis self-efficacy measures are now available [18, 26]. 
Of interest in this study is the unexplored relationship between expectancies and self efficacy 
in a cannabis sample in treatment. Based on previous research, we expect that both constructs 
will be significantly associated with cannabis use and dependence. We further anticipate that 
self-efficacy will mediate expectancy across these severity indices. 
METHOD 
Participants 
Data were obtained from 1115 individuals referred for cannabis assessment as part of 
an illicit drug diversion initiative. The diversion program consists of a 2-hour comprehensive 
assessment of substance use and psychosocial functioning incorporating motivational 
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interviewing. Referral to further treatment is provided, if indicated. Data collection from the 
program is ongoing and previous psychometric measurement studies have analysed 
subsamples of this dataset [18, 26]. The present dataset contains 382 previously unanalyzed 
cases. Importantly, all cases included in Young et al.’s [26] path analysis examining cannabis 
refusal self-efficacy were excluded to avoid ‘overfitting’ the hypothesized model. Therefore, 
none of the 1115 cases have previously been submitted to path analysis. Human ethics 
approval was obtained. 
The average age of the sample was 26.29 years (SD = 9.39). There were 878 (78.7%) 
males and 237 (21.3%) females. The majority were born in Australia (895; 80.3%) or New 
Zealand (74; 6.6%), with 26 (5.4%) identifying themselves as Indigenous Australians. 
Average weekly cannabis consumption was 3.59 (SD = 5.85) grams and the average SDS-C 
score was 3.06 (SD = 3.09). Approximately 48% were above the SDS-C screening cutoff for 
dependence (≥ 3, Swift et al., 1998). Most participants (80.7%) reported alcohol use in the 
previous month. Participants reported an average of 7.08 (SD = 8.31) drinking days in the 
past month, consuming an average of 84.52 (SD = 121.61) grams of ethanol on each drinking 
occasion. Half of the sample (52.7%) were current tobacco smokers, smoking an average of 
13.92 (SD = 9.39) cigarettes per day. 
Measures 
Cannabis Expectancy Questionnaire (CEQ) [17, 18]. The CEQ is a 45-item 
questionnaire assessing positive (18 items, e.g., “I get better ideas when smoking cannabis”) 
and negative (27 items, e.g., “I am more worried about what others are saying about me when 
I am smoking cannabis”) cannabis use outcome expectancies. Items included a five-point, 
Likert-style response format (1 = Strongly Disagree to 5 = Strongly Agree). The 
questionnaire was initially developed with a community sample and validated on a large 
sample of cannabis users recruited from an outpatient clinic. The two subscales have 
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excellent internal reliability (α ≥ .90), and the CEQ’s factor structure and criterion validity 
have been established across two samples [18]. 
Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) [25, 26]. The CRSEQ is a 14-
item questionnaire assessing an individual’s belief in their ability to resist smoking cannabis 
across various situations. Items ask respondents to rate their ability to resist smoking cannabis 
on a 6-point Likert-type scale ranging from 1 (I am very sure I could NOT resist smoking 
cannabis) to 6 (I am very sure I could resist smoking cannabis). Similar to the Drinking 
Refusal Self-Efficacy Questionnaire [27], it comprises three subscales: Emotional Relief Self-
Efficacy (6 items; e.g., “When I feel upset”), Opportunistic Self-Efficacy (5 items; e.g., 
“When someone offers me a smoke”), and Social Facilitation Self-Efficacy (3 items; e.g., 
“When I want to feel more confident”). Like the CEQ, the questionnaire was developed with 
a community sample and validated on a large sample of cannabis users recruited from an 
outpatient treatment service. The questionnaire’s internal reliability is good-to-excellent (α = 
.84 to .97), and its factor structure and criterion validity has been previously established [26]. 
Severity of Dependence Scale- Cannabis (SDS-C) [46,47]. The SDS is a 5-item 
questionnaire that is sensitive to severity of cannabis dependence [46]. Using Australian 
normative data, the SDS-C cut-off for likely cannabis dependence is ≥ 3 [47]. 
Cannabis Use was assessed by Masters- and PhD-qualified clinical psychologists 
using a retrospective diary approach over the past week. Psychologists had between 2 and 25 
years alcohol and drug treatment experience (M = 10.5 years). If cannabis was not consumed 
in the past week, an estimate of typical weekly consumption was recorded. For the purposes 
of this study, ‘joints’ (cannabis cigarette) were quantified as 0.25 grams of cannabis, and 
‘cones’ (use of ‘bong’ or ‘pipe’), 0.10 grams of cannabis. 
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Data analysis 
Structural equation modelling (SEM) was conducted in R (version 2.15.2) using the 
lavaan package (version 0.5-10) [48]. The hypothesized mediation model was tested using 
maximum likelihood estimation. The three subcomponents of cannabis refusal self-efficacy 
were operationalized as latent factors, with their items serving as indicators, all loading onto a 
higher-order refusal self-efficacy latent factor [26].  Due to the number of items on the CEQ, 
positive and negative cannabis expectancy were operationalised as latent factors with parcels 
of items serving as indicators. Item parcels were created by assigning individual CEQ items 
to parcels on an alternating basis (e.g., item 1 to parcel 1, item 2 to parcel 2, item 3 to parcel 
3, and so on) [as per 39,49].  
The χ2 test was utilized as a statistical test of model fit (α = .050) [50,51]. The 
comparative fit index (CFI), root mean-square error of approximation (RMSEA), and 
standardized root mean-square residual (SRMR) were also used to evaluate fit [50]. The 
following rules-of-thumb were employed to evaluate model fit. For “good” fit: CFI ≥ .95, 
RMSEA ≤ .06, SRMR ≤ .08 [51]. Mediation was tested in two ways. First, the hypothesized 
full mediation model was compared to alternative partial mediation models using the chi-
square difference test (Δχ2) [52]. Second, the mediation effect itself was estimated with the 
RMediation package [53] using the distribution-of-the-product method, which is the optimal 
approach to test mediation [54]. 
RESULTS 
There were data missing on CRSEQ items (range = 14.3% to 25.8%) and all CEQ 
item parcels (range = 13.1% to 25.7%). Additionally, 185 (16.6%) participants had missing 
data on weekly cannabis consumption, and 79 (7.1%) had missing SDS scores. Little’s 
Missing Completely at Random (MCAR) test revealed that the data were not MCAR, χ2 
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(3211) = 4177.60, p < .001. Closer inspection revealed that missingness on weekly cannabis 
consumption was predicted by CRSEQ Item 1 (“When I am at a party”, p < .001) and 
CRSEQ Item 2 (“When someone offers me a smoke”, p < .001). Missingness on SDS Total 
was predicted by age, with older participants being less likely to provide SDS data (p < .001). 
Missing data were imputed using Full Information Maximum Likelihood (FIML) estimation, 
an optimal strategy for handling missing data [55]. Age and sex were included in the model 
as auxiliary variables and data were consequently assumed to be Missing at Random (MAR) 
[55]. 
The hypothesized full mediation model provided a good fit to the data (Table 1, 
Model 1). This model was compared to an alternative partial mediation model for weekly 
cannabis use that included additional direct paths from positive and negative expectancy to 
weekly cannabis use. This model provided a superior fit to the full mediation model (Table 1, 
Model 2). An additional model was also tested that specified extra paths from positive and 
negative expectancy to dependence severity. This model provided the best fit to the data and 
accounted for 7% and 20% of the variance in weekly consumption and dependence severity, 
respectively (Table 1, Model 3). 
As shown in Figure 1, positive (unstandardized coefficient = -0.12, SE = 0.02, p < 
.001) and negative (unstandardized coefficient = -0.06, SE = 0.01, p < .001) cannabis 
expectancies were significantly associated with refusal self-efficacy. Refusal self-efficacy, in 
turn, predicted weekly cannabis use (unstandardized coefficient = -0.94, SE = 0.18, p < .001) 
and severity of dependence (unstandardized coefficient = -0.55, SE = 0.09, p < .001). Self-
efficacy fully mediated the association between negative expectancy and weekly 
consumption (unstandardized mediation effect, CI95% = 0.03, 0.17). However, refusal self-
efficacy only partially mediated the effect of positive expectancy on weekly consumption 
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(unstandardized mediation effect, CI95% = 0.06, 0.17). It still had a significant direct 
association with consumption (unstandardized coefficient = 0.26, SE = 0.08, p < .001).  
Cannabis refusal self-efficacy fully mediated the association between positive 
expectancy and severity of dependence (unstandardized mediation effect, CI95% = 0.04, 
0.10). However, refusal self-efficacy only partially mediated the effect of negative 
expectancy on dependence severity (unstandardized mediation effect, CI95% = 0.02, 0.06). 
Negative expectancy still had a significant direct association with severity of dependence 
(unstandardized coefficient = 0.21, SE = 0.03, p < .001). 
______________________ 
Insert Table 1 about here 
______________________ 
______________________ 
Insert Figure 1 about here 
______________________ 
 
DISCUSSION 
Cannabis expectancies and cannabis refusal self-efficacy beliefs have been 
independently associated with problematic use and treatment outcome. Applying Social 
Cognitive Theory (SCT) [6,7], this is the first study to examine the possible mediational 
relationship between expectancy and self-efficacy beliefs, as observed in other substance use. 
We applied newly developed, robust psychometric tools to a large clinical sample of cannabis 
users in treatment (N = 1115). Findings provide partial support for a meditational relationship 
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between cannabis expectancies and cannabis refusal self-efficacy (see Table 2; Figure 1). 
Cannabis refusal self-efficacy fully mediated negative expectancy in predicting consumption 
and fully mediated positive expectancy in predicting dependence severity.  
______________________ 
Insert Table 2 about here 
______________________ 
We confirm previous reports [14,18] that positive cannabis expectancies, but not 
negative expectancies, were a direct and significant predictor of cannabis consumption. Full 
mediation was observed when self-efficacy beliefs and negative expectations were combined 
in the one model, identifying a previously unreported pathway to cannabis consumption. 
Consistent with the SCT hypothesis, cannabis refusal self-efficacy played a mediating role 
predicting cannabis dependence severity. Full mediation was observed for positive 
expectancy, partial mediation for negative expectancy. Positive expectancies were only 
associated with cannabis severity via their association with low self-efficacy beliefs. Negative 
expectancies were directly associated with dependence severity, as well as indirectly though 
self-efficacy factors.  
The study has limitations. While the sample size for treatment seeking cannabis users 
is large and measurement robust, the cross-sectional design does not allow an assessment of 
causality. In analogous research, prospective alcohol studies suggest that alcohol 
expectancies develop early, even vicariously [56], and play a significant role in predicting 
future alcohol problems [40]. Low self-efficacy beliefs are associated with post-treatment 
abstinence [57,58]. We cannot determine from these data if similar trajectories are evident for 
cannabis, as for alcohol. The findings may not be generalizable to all treatment seeking 
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samples and in particular we also had a high proportion of males. Biological markers of 
cannabis use over a longer period would have strengthened confidence in self-report 
consumption data. Greater power from expectancies and self-efficacy in predicting cannabis 
use over specific periods may be obtained if the assessment focuses more closely on that 
period, which may not be the same as those before or afterwards. SCT emphasises the 
contextual grounding of both self-efficacy (the specific task difficulty, physiological and 
emotional state, and amount of effort that the person expects to expend) and outcome 
expectancies. The expected outcomes of further cannabis use prior to finalisation of the 
clinical and forensic issues in the current sample may be different from the expected 
outcomes in the past or future.  
The current findings indicate that modification of high negative and positive 
expectancies may be equally important targets in psychological interventions aimed at 
reducing consumption. Consistent with Bandura [8,9], low self-efficacy beliefs could be the 
final contributing pathway to heavier cannabis consumption. These are likely to provide 
additional efficacy as targets in cannabis prevention and treatment. In alcohol dependence, 
treatments aimed at developing alcohol refusal skills are effective, with therapeutic effects 
being mediated by increased self-efficacy [59]. By contrast, direct alcohol expectancy 
challenges have shown only modest efficacy, at least in prevention studies [60]. Given the 
strong association between expectancies and refusal self-efficacy found for both alcohol and 
cannabis, future research needs to investigate if added benefit occurs by combining these two 
approaches. Results reported here suggest that this could provide incremental benefit. 
Consistent with previous theoretical and empirical alcohol studies, both cannabis 
expectancy and cannabis refusal self-efficacy were significant predictors of cannabis 
problems. When mediation was formally examined, partial support was observed for self-
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efficacy mediating expectancy beliefs. Preliminary evidence suggests both constructs are 
important in the aetiology of cannabis use disorders.  
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Table 1 
Fit Indices for Full and Partial Mediation Models of Cannabis Cognitions and Use (N = 
1115) 
Model χ2 (df) CFI RMSEA 
(CI90%) 
SRMR Δχ2 (df) 
      
1. Full mediation model 1608.28* (314) .94 .06 (.058 - 
.064) 
.05  
2. Partial mediation model 
(Weekly cannabis use) 
1595.35* (312) .94 .06 (.058 - 
.064) 
.05 12.93# (2) 
3. Partial mediation model 
(Weekly use & 
dependence) 
1540.19* (310) .94 .06 (.057 - 
.063) 
.05 55.17* (2) 
Note. CFI = Comparative Fit Index; RMSEA = Root Mean-Square Error of Approximation; SRMR = 
Standardized Root Mean-Square Residual. 
#
p = .002; * p < .001. 
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Table 2. Tests of Mediation Summary 
Expectancy Self-Efficacy 
Partial Mediation 
Self-Efficacy  
Full Mediation 
 
Predicting Cannabis Consumption 
 
Positive X -- 
Negative -- X 
 
Predicting Cannabis Dependence Severity (SDS) 
 
Positive -- X 
Negative X -- 
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Figure Legends 
Figure 1. Partial mediation model of the relationship between cannabis expectancy, cannabis 
refusal self-efficacy, weekly cannabis use and dependence severity. Standardized parameter 
estimates are presented. All estimates are statistically significant at p < .05, except where 
indicated (#).
 29 
 
 30 
 
 
